HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Tan, Y. Articles by Jaffa, A. A. Search for Related Content PubMed PubMed Citation Articles by Tan, Y. Articles by Jaffa, A. A.

Mechanisms through which bradykinin promotes glomerular injury in diabetes

Division of Endocrinology-Diabetes-Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina

Submitted 4 May 2004 ; accepted in final form 20 October 2004

In diabetes, mesangial cell proliferation and extracellular matrix expansion are critical components in the development of glomerulosclerosis. We reported that diabetes alters the activity of the kallikrein-kinin system and that these alterations contribute to the development of diabetic nephropathy. The present study examined the influence of streptozotocin-induced diabetes on the renal expression of bradykinin (BK) B₂ receptors (B₂KR), connective tissue growth factor (CTGF), transforming growth factor- (TGF-), and TGF- type II receptor (TGF-RII) and assessed the signaling mechanisms through which B₂KR activation may promote glomerular injury. Eight weeks after the induction of diabetes, renal mRNA levels of B₂KR, CTGF, and TGF- as well as protein levels of CTGF and TGF-RII were measured in control (C), diabetic (D), and insulin-treated diabetic (D+I) rats. Renal B₂KR and TGF- mRNA levels expressed relative to -actin mRNA levels and CTGF and TGF-RII protein levels were significantly increased in D and D+I rats compared with C rats (P < 0.03, n = 5). To assess the contribution of B₂KR activation on modulating the expression of CTGF, TGF-RII, and collagen I, mesangial cells (MC) were treated with BK (10^–8 M) for 24 h and CTGF and TGF-RII protein levels were measured by Western blots and collagen I mRNA levels were measured by RT-PCR. A two- to threefold increase in CTGF and TGF-RII protein levels was observed in response to BK stimulation (P < 0.001, n = 6). In addition, a marked increase in collagen I mRNA levels was observed in response to BK stimulation. Treatment of MC with BK (10^–8 M) for 5 min significantly increased the tyrosine phosphorylation of p60src kinase and of p42/p44 MAPK (P < 0.05, n = 4). Inhibition of src kinase by PP1 (10 µM) inhibited the increase in p42/p44 MAPK activation in response to BK. Finally, to determine whether BK stimulates CTGF, TGF-RII, and collagen I expression via activation of MAPK pathways, MC were pretreated with an inhibitor of p42/p44 MAPK (PD-98059) for 45 min, followed by BK (10^–8 M) stimulation for 24 h. Selective inhibition of p42/p44 MAPK significantly inhibited the BK-induced increase in CTGF, TGF-RII, and collagen I levels. These findings are the first to demonstrate that BK regulates the expression of CTGF, TGF-RII, and collagen I in MC and provide a mechanistic pathway through which B₂KR activation may contribute to the development of diabetic nephropathy.

glomerulosclerosis; diabetic nephropathy; connective tissue growth factor

This article has been cited by other articles:

				Y. Tan, J.-S. Keum, B. Wang, M. B. McHenry, S. R. Lipsitz, and A. A. Jaffa Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1026 - F1035. [Abstract] [Full Text] [PDF]

				J. Allard, M. Buleon, E. Cellier, I. Renaud, C. Pecher, F. Praddaude, M. Conti, I. Tack, and J.-P. Girolami ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1083 - F1092. [Abstract] [Full Text] [PDF]

				A.-H. Yang, S.-W. Huang, J.-Y. Chen, J.-K. Lin, and C.-Y. Chen Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: A functional implication for peritoneal fibrosis Nephrol. Dial. Transplant., March 1, 2007; 22(3): 756 - 762. [Abstract] [Full Text] [PDF]

				W. Zhang, H. Meng, Z.-H. Li, Z. Shu, X. Ma, and B.-X. Zhang Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1054 - F1064. [Abstract] [Full Text] [PDF]

				J. Chao, H.-J. Li, Y.-Y. Yao, B. Shen, L. Gao, G. Bledsoe, and L. Chao Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity Hypertension, March 1, 2007; 49(3): 490 - 497. [Abstract] [Full Text] [PDF]